Craig Zeman, MD
Adult Reconstructive Orthopaedic Surgery · Oxnard, CANPI 1710943618
Payments from drug & device makers
Across 25 payments — averaging $39.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$344
- Cornerstone Medical Associates, Inc.$116
- Medartis Inc.$106
- Pacira Therapeutics, Inc.$95
- Micromed Inc$93
- Bioventus LLC$90
- plus $153 from 5 others
What the payments were for
- Food & beverage$997100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 5 | $344 |
| Cornerstone Medical Associates, Inc. | 1 | $116 |
| Medartis Inc. | 1 | $106 |
| Pacira Therapeutics, Inc. | 4 | $95 |
| Micromed Inc | 1 | $93 |
| Bioventus LLC | 3 | $90 |
| Endo Pharmaceuticals Inc. | 4 | $72 |
| Vertex | 1 | $30 |
| Pacira Pharmaceuticals Incorporated | 1 | $24 |
| Team_makena_llc | 3 | $19 |
| Terumo BCT, Inc. | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$997 in reported general payments places this provider in the 20th percentile of 136 adult reconstructive orthopaedic surgery providers in California.
See all adult reconstructive orthopaedic surgery providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 124 | $2,952 |
| Meloxicam | 637 | $1,619 |
| Prednisone | 158 | $745 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 65 | $730 |
| Diclofenac Sodium | 37 | $386 |
| Promethazine Hcl | 34 | $177 |
| Tramadol Hcl | 19 | $62 |
| Ibuprofen | 11 | $48 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Oxnard
- William MaloneyStanford$11.1M
- James CaillouetteNewport Beach$4.8M
- William LongLos Angeles$2.8M
- John DearbornMenlo Park$2.5M
- James HuddlestonStanford$2.2M
- William Bugbeela Jolla$2.2M
- Alexander SahFremont$1.8M
- John DianaNapa$1.1M
- Louis KwongTorrance$958K
- Derek AmanatullahStanford$935K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.